3 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
Follow Hemolysis: new trials by email Literature Review of Hemolysis trials Research Report on Hemolysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3 Peginterferon alfa-2a, Ribavirin - Hepatitis C | Phase 4 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 58 | 2003-03-01 | 2013-12-06 |
| Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C With and Without Kidney Disease Peginterferon alfa-2a with Ribavirin, Peginterferon alfa-2a - Chronic Hepatitis C | Phase 4 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 50 | 2001-12-01 | 2013-11-08 |
| Long-Term Therapy With Ribavirin for Chronic Hepatitis C Ribavirin - Chronic Hepatitis C | Phase 4 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 50 | 1999-02-12 | 2017-07-02 |
Anemia, Hemolytic (3) · Fibrosis (3) · Hepatitis C (3) · Hepatitis C, Chronic (2) · Hepatitis, Chronic (2) · Hepatitis (1) · Liver Diseases (1) · Neutropenia (1) · Renal Insufficiency (1)
Anemia (3) · Blood-Borne Infections (3) · Communicable Diseases (3) · Digestive System Diseases (3) · Flaviviridae Infections (3) · Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Hepatitis, Viral, Human (3) · Infections (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · RNA Virus Infections (3) · Virus Diseases (3) · Chronic Disease (2) · Disease Attributes (2)
Ribavirin (3) · peginterferon alfa-2a (2)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (3)
United States (3)
Rotman Yaron, MD (1) · Yaron Rotman, MD (1)